| Literature DB >> 27934892 |
Assaf Malik1,2, Vered Domankevich1,3, Han Lijuan4, Fang Xiaodong4, Abraham Korol1,3, Aaron Avivi1, Imad Shams1,3.
Abstract
The subterranean blind mole rat, Spalax, experiences acute hypoxia-reoxygenation cycles in its natural subterranean habitat. At the cellular level, these conditions are known to promote genomic instability, which underlies both cancer and aging. However, Spalax is a long-lived animal and is resistant to both spontaneous and induced cancers. To study this apparent paradox we utilized a computational procedure that allows detecting differences in transcript abundance between Spalax and the closely related above-ground Rattus norvegicus in individuals of different ages. Functional enrichment analysis showed that Spalax whole brain tissues maintain significantly higher normoxic mRNA levels of genes associated with DNA damage repair and DNA metabolism, yet keep significantly lower mRNA levels of genes involved in bioenergetics. Many of the genes that showed higher transcript abundance in Spalax are involved in DNA repair and metabolic pathways that, in other species, were shown to be downregulated under hypoxia, yet are required for overcoming replication- and oxidative-stress during the subsequent reoxygenation. We suggest that these differentially expressed genes may prevent the accumulation of DNA damage in mitotic and post-mitotic cells and defective resumption of replication in mitotic cells, thus maintaining genome integrity as an adaptation to acute hypoxia-reoxygenation cycles.Entities:
Mesh:
Year: 2016 PMID: 27934892 PMCID: PMC5146665 DOI: 10.1038/srep38624
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Functionally enriched terms among genes significantly up/down regulated in Spalax vs. rat, in the brain, at above two fold change.
| Category | Functional terms | Adjusted | ||||
|---|---|---|---|---|---|---|
| CP | GP | GS | GR | DE | ||
| Log2FC > 1.0 Adj. | (I) DNA metabolic process | 102 | ||||
| (I) DNA replication/DNA-dependent DNA replication | 23 | |||||
| (I) DNA repair | 59 | |||||
| (I) Fanconi Anemia pathway (KEGG) | 6.3E-02 | 13 | ||||
| (I) cellular response to DNA damage stimulus | 9.4E-02 | 79 | ||||
| (I) DNA recombination/recombinational repair | 29 | |||||
| (II) homologous chromosome segregation | 9.4E-02 | 11 | ||||
| (II) kinetochore/condensed chromosome kinetochore | 22 | |||||
| (II) chromosomal region/centromeric region | 9.4E-02 | 38 | ||||
| (II) Cell cycle/Mitotic Metaphase | 8.1E-02 | 9.5E-02 | 88 | |||
| (III) extracellular matrix/proteinaceous extracellular matrix | 56 | |||||
| (III) heparin binding | 20 | |||||
| (III) ECM-receptor interaction | 9.5E-02 | 17 | ||||
| Log2FC < 1.0 Adj. | (IV) extracellular space | 119 | ||||
| (IV) extracellular vesicle/lysosome/exosome | 254 | |||||
| (V) G-protein coupled receptor activity/G-protein complex | 5.4E-02 | 75 | ||||
Category column: (1) genes significantly up-regulated in Spalax vs. rat, in the brain, with at least two fold increase (log2FC > 1.0); (2) genes down-regulated, with least two fold decrease (log2FC < −1.0); Terms column: groups of functionally-related terms are marked in Roman numerals; Adjusted p values heatmap: FDR-corrected p values reported by the programs cluster-profiler (CP), g-profiler (GP), goseq (GS), and Gorilla (GR). The total count of DE genes is shown in the last column (DE). Note that Gorilla tool does not include a KEGG/Reactome databases, and terms that were not tested, or were not found to be enriched by specific tools, are shown as blank cells. Significant p-values are underlined, and p-values > 10−1 in italics.
Functionally enriched terms among all significantly up/down regulated in Spalax vs. rat, in the brain.
| Category | Term (LR-Path RNA-enrich) | adj. p value | Background | DE |
|---|---|---|---|---|
| Significantly upregulated (spalax > rat) | (I) DNA Replication | 70 | 48 | |
| (I) DNA metabolic process | 647 | 273 | ||
| (I) DNA Repair | 98 | 76 | ||
| (I) DNA Damage | 100 | 79 | ||
| (I) MCM complex | 8 | 6 | ||
| (II) condensed chromosome kinetochore | 9 | 8 | ||
| (II) nuclear chromosome | 227 | 126 | ||
| (II) condensed chromosome, centromeric region | 13 | 11 | ||
| (II) nuclear chromosome part | 209 | 116 | ||
| (II) Centromere | 24 | 18 | ||
| (II) Chromosome Maintenance | 27 | 22 | ||
| (II) CDK Regulation of DNA Replication | 9 | 7 | ||
| (III) heme-copper terminal oxidase activity | 5 | 3 | ||
| Significantly downregulated (spalax < rat) | (IV) Ubiquitin proteasome pathway | 27 | 16 | |
| (IV) HECT-domain (ubiquitin-transferase) | 17 | 8 | ||
| (IV) Ubiquitins | 77 | 48 | ||
| (IV) unfolded protein binding | 38 | 27 | ||
| (IV) proteasome regulatory particle | 12 | 8 | ||
| (V) NADH dehydrogenase complex | 21 | 11 | ||
| (V) mitochondrial respiratory chain | 22 | 12 | ||
| (V) mitochondrial inner membrane | 200 | 111 | ||
| (V) respiratory chain | 40 | 13 | ||
| (V) NADH dehydrogenase activity | 15 | 8 | ||
| (V) Hexokinase | 6 | 4 | ||
| (V) Parkinson’s disease | 43 | 28 | ||
| (VI) anion channel activity | 38 | 19 | ||
| (VI) sodium channel regulator activity | 18 | 9 | ||
| (VII) extracellular vesicular exosome | 1142 | 791 |
The table shows significantly enriched terms among all significantly up- or down-regulated genes, in Spalax vs. rat, using the tool LR-Path RNA-enrich. This tool corrects for read-counts biases (Methods). In this test all significantly regulated genes were defined as DE (for all fold-change differences); Terms column: groups of functionally-related terms are marked in Roman numerals. Significant p-values are underlined.
Figure 1Heatmap representation of transcript abundance differences among genes belonging to the DNA repair functional group, between Spalax and rat individuals.
Each heatmap’s cell shows the division of an individual FPKM from the mean FPKM of all individuals. Rows represent repair genes, significantly up- or down-regulated (fold change >2 or < −2, adj. P value < 0.05), in Spalax vs. rat. The columns represent individuals, labeled “r”, and “s”, (rat and Spalax, respectively), sorted by their species and ages. DNA repair genes were significantly overrepresented among Spalax upregulated genes (Table 1).
Figure 2Significant overrepresentation of genes involved in DNA replication, among Spalax upregulated genes, compared to rat.
Among upregulated Spalax genes (fold change >2, adj. P value < 0.05), compared to rat, a significant overrepresentation of genes involved in DNA replication is seen. Larger than two fold upregulated/downregulated Spalax genes are superimposed on the significantly enriched DNA-replication pathway of rat (rno03030, obtained by KEGG, Kanehisa Laboratories), and are shown in green to red scale (mapped to negative to positive fold changes values, namely down and up regulation, respectively).
Figure 3Significant overrepresentation of genes involved in the Fanconi Anemia pathway, among Spalax upregulated genes, compared to rat.
Among upregulated Spalax genes (fold change >2, adj. P value < 0.05), compared to rat, a significant overrepresentation of genes involved in the Fanconi Anemia pathway is seen. Larger than two fold upregulated/downregulated Spalax genes are superimposed on the significantly enriched DNA-replication pathway of rat (rno03460, obtained by KEGG, Kanehisa Laboratories), and are shown in green to red scale (mapped to negative to positive fold changes values, namely down and up regulation, respectively).
Figure 4Comparison of RNA-Seq normalized read counts, to the normalized Real time Quantitative PCR copy numbers.
The upper panel shows the RNA-Seq read normalized counts (log2FPKM) for seven genes, five upregulated in Spalax vs. rat in the brain, and two downregulated. The lower panel shows log2 normalized Real time Quantitative PCR copy numbers for the same genes, in Spalax vs. rat brain samples. In six out of seven tests, the results of both methods show the same trend, with significant DE. Figure S4 shows the same comparison against total qPCR copy numbers, rather than normalized copy numbers.
Figure 5Suggested model of genome stability maintenance in Spalax.
(A) Spalax endures oxygen fluctuations in subterranean environments induce oxidative-stress; (B) Under hypoxia, dNTPs are depleted, replication is arrested, and transcript abundance of genes in DNA-repair pathways is halted. Reoxygenation after short-term hypoxia leads to replication restart and is accompanied by oxidative stress, which induces additional DNA damage. Yet, compared to murines, Spalax shows a higher normoxic transcript abundance of repair and DNA-metabolic genes, which may allow better responses to hypoxia-reoxygenation; (C) Depleted dNTPs and additional DNA damage lead to stalled/collapsed replication fork and enhanced replication stress at the same time when DNA repair pathways have not yet recovered; (D) Putative protective mechanisms in Spalax cells may include counteracting a shortage of repair genes and replication factors by up-regulating repair pathways (e.g., HR, FA, and MMR), oxidative damage repair (e.g., BER), stabilizing of stalled forks, and restarting stalled/collapsed forks.
Known functions of DNA-repair and DNA-metabolism genes, DE at higher levels in Spalax compared to rat.
| Strategy | Pathway | Symbol | Role in the pathway (reference) |
|---|---|---|---|
| Availability of replication factors | replication | RPAIN* | Imports RPA into the nucleus. RPA stabilizes ssDNA and prevents its reannealing, recruits and activates different proteins and complexes involved in DNA metabolism and repair |
| POLA1,2 | Replication initiation. Part of the DNA polymerase alpha complex | ||
| RFC3,5 | Replication elongation. Part of the RFC complex clump loader (load f PCNA onto DNA) | ||
| FEN1 | Cleaves the 5-overhanging flap structure that is generated during replication | ||
| POLG | Replication and repair in the mitochondria | ||
| Enhanced repair of mismatched bases during replication | MMR | RFC3,5 | Part of the RFC complex. Involved in mismatch-provoked excision |
| MSH6 | Mismatch recognition complex. MSH2/MSH6 (MutSa) heterodimer | ||
| PMS2 | Part of the MutLa which in complex with MutSa and in the presence of RFC and PNCA, introduces single-strand breaks near the mismatch to enable degrading the strand | ||
| WRN | Interacts with RPA and MutLα (MLH1-PMS2) as well as MutSa (MSH2/MSH6) and MutSβ (MSH2/MSH3), which stimulate its helicase activity | ||
| RPA | Binds nicked DNA before MutSα and MutLα, stimulates mismatch-provoked excision, protects ssDNA gapped region, facilitates DNA re-synthesis, and stimulates WRN | ||
| Stabilizing stalled forks | ATR path. | RAD1 | Part of the 9-1-1 complex that associates with TOPBP1 to stimulate ATR kinase activity |
| RPA | stabilizes ssDNA, recruitment of ATRIP to activate ATR kinase | ||
| TOPBP1 | Activation of ATR signaling cascade and CHK1 phosphorylation | ||
| TIMELESS | Associates with RPA2 to stabilize stalled forks and to promote the accumulation of CHK1 to RPA-ssDNA regions where it can be activated by ATR | ||
| Repair lesions that may stall the replication fork | BER | RAD1 | Part of the 9-1-1 complex - a sliding clamp platform on DNA for several proteins involved in long-patch BER (LP-BER). Stimulates POLB, FEN1, and LIG1 activity |
| FEN1 | Cleaves within the apurinic/apyrimidinic (AP) site-terminated flap. Prevents flaps from equilibrating into structures that lead to duplications and deletions. | ||
| NTHL1 | DNA glycosylase activity (substrates containing oxidized pyrimidine) and AP lyase activity | ||
| PNKP | Ensures that DNA termini are compatible with extension and ligation | ||
| SMUG1 | DNA glycosylase that removes uracil from ssDNA and ssDNA. initiates BER | ||
| UNG | Eliminating uracil from DNA molecules by cleaving the N-glycosylic bond. initiates BER | ||
| ALKBH2 | Repair of alkylated DNA | ||
| MPG | Resolve alkylation lesions by hydrolysis of deoxyribose N-glycosidic bond | ||
| WRN | Participates in LP- BER by unwinding 5′ flaps and interacting with BER proteins | ||
| RNA:DNA hybrids | RNASEH1 | Endonuclease that specifically degrades RNA of RNA-DNA hybrids | |
| BRCA2 | Interacts with the transcription and export complex 2, required to prevent R-loop-associated DNA damage | ||
| Collapsed-fork restart, DSBs and ICL repair | ATM path. | MRE11A | Part of the MRN complex. Possesses single-strand endonuclease and double-strand-specific 3-5 exonuclease activities. Required for ATM kinase signaling. |
| ATM | DNA damage sensor. Phosphorylates H2AX/H2AFX at DSBs | ||
| MDC1 | Interacts with phosphorylated H2AX near sites of DNA DSBs. facilitates recruitment of the ATM and MRE11. | ||
| EYA3 | Promote the recruitment of DNA repair complexes containing MDC1. | ||
| HR | MCM8 | Part of the MCM8-MCM9 complex, involved in HRR following ICL. Promotes resection of DSB ends by MRN complex and RAD51 recruitment | |
| TOP3A | Essential component of the RMI complex that plays an important role in the processing of HR intermediates to limit DNA crossover formation in cells. | ||
| BRCA2 | Target RAD51 to displace RPA from ssDNA and stabilize RAD51-ssDNA filaments. Involved in POLH localization at collapsed fork | ||
| RAD51C | Part of BCDX2 and CX3 complexes that bind to the intersection of the four duplex arms of the Holliday junction (HJ) and to junction of replication forks. | ||
| XRCC3 | Part of the CX3 complex. Involved in HJ resolution and in processing HR intermediates, downstream RAD51 | ||
| NSMCE1 | Component of the SMC5-SMC6 complex, involved in DSBs repair by HR and may promote sister chromatid HR by recruiting the SMC1-SMC3 cohesin complex to DSBs. | ||
| FA** | PMS2 | Part of MutLa that interacts with FANCJ | |
| FANCD2 | Promotes BRCA2 loading onto damaged chromatin Recruit POLH | ||
| FANCA | Serves as a docking or anchor point at the site of ICL damage for the FA core complex. Interacts with BRCA1 | ||
| RUVBL1 | Controlling the cellular abundance of FA core complex | ||
| TSL | POLH/I | Incorporating nucleotides opposite a variety of lesions thereby bypasses the lesions | |
| USP1 | Involved in PCNA-mediated TLS by de-ubiquitinating mono-ubiquitinated PCNA |
Selected pathways and the role of each gene in the pathway are specified in the table. Information was obtained from a literature survey (unless mentioned otherwise, data was obtained from GeneCards). An extended list of DE genes is provided in Supplementary Table S2. ‘*’ The differentially expressed gene was RPAIN, however, we refer to the function of RPA; ‘**’ in addition to genes calcified under the FA category in the table, additional genes classified under HR and TLS categories in fact participate in the FA pathways as well.